AL
Alumis Inc.
ALMS · NASDAQ
$9.90 -6.16% (-$0.65)
1M -61.25%
Market Cap $1.22B
P/E Ratio -
Div. Yield -
ROE 102.97%
Piotroski F-Score Weak
2/9Valuation
36 /100
Fair P/S 165.18x
P/B 2.70x
P/E N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 88.23%
Net margin 5,933.45%
Op. margin 6,204.39%
Quality
0 /100
Poor ROIC 93.45%
ROE 102.97%
ROA 78.30%
Debt
100 /100
Low Debt/Equity 0.08x
Current ratio 6.74x
Int. coverage N/A
Stability
19 /100
Unstable Beta -0.67x
EPS volatility 186.73%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ALMS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Martin Babler
Employees
237
Headquarters
South San Francisco
Nadcházející události
12 LIS
Earnings
Upcoming earnings report